These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 37205307)

  • 1. Gut microbiota, an emergent target to shape the efficiency of cancer therapy.
    Kouidhi S; Zidi O; Belkhiria Z; Rais H; Ayadi A; Ben Ayed F; Mosbah A; Cherif A; El Gaaied ABA
    Explor Target Antitumor Ther; 2023; 4(2):240-265. PubMed ID: 37205307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Gut Microbiota in Lung Cancer: From Carcinogenesis to Immunotherapy.
    Liu X; Cheng Y; Zang D; Zhang M; Li X; Liu D; Gao B; Zhou H; Sun J; Han X; Lin M; Chen J
    Front Oncol; 2021; 11():720842. PubMed ID: 34490119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
    Ting NL; Lau HC; Yu J
    Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the complex and multifaceted interplay of the gut microbiome and cancer prevention and therapy.
    Kashyap S; Das A
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):85-99. PubMed ID: 37307215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation in cancer management: Current status and perspectives.
    Chen D; Wu J; Jin D; Wang B; Cao H
    Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Shapes the Efficiency of Cancer Therapy.
    Ma W; Mao Q; Xia W; Dong G; Yu C; Jiang F
    Front Microbiol; 2019; 10():1050. PubMed ID: 31293523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
    Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota modulation: a tool for the management of colorectal cancer.
    Wang Y; Li H
    J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
    Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
    Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond.
    Sahle Z; Engidaye G; Shenkute Gebreyes D; Adenew B; Abebe TA
    SAGE Open Med; 2024; 12():20503121241257486. PubMed ID: 38826830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer.
    Fong W; Li Q; Yu J
    Oncogene; 2020 Jun; 39(26):4925-4943. PubMed ID: 32514151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host Microbiomes in Tumor Precision Medicine: How far are we?
    D'Amico F; Barone M; Tavella T; Rampelli S; Brigidi P; Turroni S
    Curr Med Chem; 2022; 29(18):3202-3230. PubMed ID: 34986765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
    Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
    Front Immunol; 2021; 12():704942. PubMed ID: 34489956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.